- MeSH
- Injections, Subcutaneous methods nursing utilization MeSH
- Immunoglobulins, Intravenous administration & dosage MeSH
- Immune System Diseases MeSH
- Nursing Care standards MeSH
- Reference Standards MeSH
- Immunologic Deficiency Syndromes diagnosis classification complications therapy MeSH
- Nurses MeSH
- Drug Administration Routes MeSH
Specifická alergenová imunoterapie (SAIT) představuje jediný způsob léčby, který je schopen zvrátit přirozený průběh alergického onemocnění. Není léčbou konkrétního onemocnění, ale navozuje toleranci alergenu, který je příčinou jeho vzniku. Je účinná v léčbě alergické rýmy, alergického astmatu a alergie na jed blanokřídlého hmyzu. SAIT redukuje příznaky těchto chorob, ale je i prevencí jejich progrese a prevencí rozvoje další senzibilizace pacienta. Efekt SAIT přetrvává několik let po jejím ukončení. Specifickou alergenovou imunoterapii podáváme ve formě subkutánní nebo sublinguální, která je považována za bezpečnější a pro pacienta organizačně méně náročnou.
Allergen specific immunotherapy is the only treatment that has the potential to alter the natural course of allergic disease. It modifies the immunological response to alergen which causes the developing of the disease. It is effective in allergic rhinitis, allergic asthma and Hymenoptera venom allergy. It´s beneficial effect maintains for years after it has been discontinued and it concerns not only the reduction of symptoms of certain disease, but aslo the prevention of progression of the disease and the onset of new sensitisations. There are two forms of alergen immunotherapy available: subcutaneous and sublingual, the latter beeing more safe and more patient´s friendly.
- MeSH
- Allergens isolation & purification classification MeSH
- Hypersensitivity * diagnosis prevention & control therapy MeSH
- Allergy and Immunology trends MeSH
- Desensitization, Immunologic * methods trends utilization MeSH
- Immunoglobulin E isolation & purification drug effects MeSH
- Injections, Subcutaneous methods trends utilization MeSH
- Disease Attributes MeSH
- Humans MeSH
- Interdisciplinary Communication MeSH
- Immune System Diseases diagnosis prevention & control therapy MeSH
- Preventive Medicine methods trends MeSH
- Sublingual Immunotherapy methods trends utilization MeSH
- Outcome and Process Assessment, Health Care * MeSH
- Check Tag
- Humans MeSH
- Keywords
- IDegLira (produkt dánské společnosti NovoNordisk pod prodejním názvem Xultophy - skládá se z inzulinového analoga degludeku a a analoga GLP-1 iraglutidu),
- MeSH
- Diabetes Mellitus, Type 2 drug therapy prevention & control therapy MeSH
- Insulin, Long-Acting administration & dosage adverse effects therapeutic use MeSH
- Drug Combinations * MeSH
- Drug Evaluation MeSH
- Precision Medicine methods trends utilization MeSH
- Injections, Subcutaneous methods utilization MeSH
- Insulins * administration & dosage adverse effects therapeutic use MeSH
- Clinical Trials as Topic MeSH
- Humans MeSH
- Liraglutide * administration & dosage adverse effects therapeutic use MeSH
- Statistics as Topic MeSH
- Titrimetry methods utilization MeSH
- Check Tag
- Humans MeSH
- Keywords
- studie PrefHer,
- MeSH
- Injections, Subcutaneous utilization MeSH
- Administration, Intravenous methods MeSH
- Humans MeSH
- Breast Neoplasms * drug therapy MeSH
- Subcutaneous Absorption MeSH
- Antineoplastic Agents pharmacology therapeutic use MeSH
- Randomized Controlled Trials as Topic MeSH
- Receptor, ErbB-2 MeSH
- Trastuzumab * administration & dosage pharmacology therapeutic use MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Comparative Study MeSH
Stav pacientov v pokročilých štádiách nevyliečiteľných ochorení, najmä seniorov a terminálnych pacientov v paliatívnej starostlivosti, často vyúsťuje do neschopnosti príjmať lieky a tekutiny perorálnym spôsobom. Autorky príspevku poukazujú na bezpečnú, jednoduchú a šetrnú možnosť podania tekutín prostredníctvom podkožnej aplikácie - hypodermoklýzy, jej praktický aspekt, výhody i kontraindikácie.
The health condition of patient in advanced state who suffer from incurable disease, mainly seniors and terminal patient in paliative care, faces often to disablity of accepting drugs and liquids. The authors of contribution point to safe, easy and economical possibility of giving liquids through hyperdermatic application - hyperdemoclysis, its practical view, advantages and contra-indication.
- MeSH
- Administration, Cutaneous MeSH
- Dehydration prevention & control therapy MeSH
- Hypodermoclysis classification contraindications methods standards nursing instrumentation trends utilization MeSH
- Injections, Subcutaneous utilization MeSH
- Palliative Care methods MeSH
- Terminal Care methods MeSH
- Infusions, Subcutaneous utilization MeSH
- Drug Administration Routes MeSH
- Keywords
- farmakologická sedace formou "standing sedation",
- MeSH
- Conscious Sedation * methods utilization MeSH
- Antiparasitic Agents administration & dosage therapeutic use MeSH
- Animal Husbandry methods organization & administration MeSH
- Animals, Wild MeSH
- Equidae * MeSH
- Injections, Subcutaneous methods utilization MeSH
- Blood Specimen Collection MeSH
- Tetanus Toxoid administration & dosage therapeutic use MeSH
- Vaccination methods veterinary utilization MeSH
- Veterinary Medicine methods MeSH
- Animals, Zoo * MeSH
Roztroušená skleróza (RS) je chronické autoimunitní onemocnění, které postihuje centrální nervový systém (CNS). Včasné zahájení terapie může celý proces zpomalit. V článku se zabýváme lokálními nežádoucími účinky v místě vpichu při použití glatiramer acetátu (GA) – Copaxone ® a především ovlivněním lokální reakce prostřednictvím techniky LPG-endermoterapie. Jedná se unikátní technologii, která vznikla na základě osobních zkušeností zakladatele a tvůrce pana Louise Paula Guitaye (LPG). Endermoterapie je mechanická stimulace citlivé tkáně speciální lift hlavicí, při které dochází k aktivaci fibroblastů, stimulaci lymfatického i krevního systému a vede k novotvorbě kolagenu a elastinu.
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS). Early initiation of treatment can slow down the whole process. The article deals with local adverse effects at the injection site when using glatiramer acetate (GA) – Copaxone®, and, in particular, with interfering with the local response by means of the LPG-endermotherapy technique. It is a unique technology that was developed based on personal experience of the founder and author, Mr. Louis Paul Guitay (LPG). Endermotherapy is mechanical stimulation of sensitive tissue with a special lift head during which activation of fibroblasts and stimulation of both the lymphatic and blood systems occur, leading to collagen and elastin neoformation.
- Keywords
- Komplikace dlouhodobé terapie Glatiramer acetátem, LPG-endermoterapie,
- MeSH
- Atrophy complications prevention & control therapy MeSH
- Injections, Subcutaneous * methods adverse effects utilization MeSH
- Humans MeSH
- Panniculitis diagnosis etiology complications MeSH
- Peptides * administration & dosage adverse effects therapeutic use MeSH
- Subcutaneous Fat pathology drug effects MeSH
- Multiple Sclerosis * drug therapy complications prevention & control MeSH
- Statistics as Topic MeSH
- Adipose Tissue * pathology drug effects MeSH
- Outcome and Process Assessment, Health Care methods utilization MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
- Keywords
- Copaxone inj. (,
- MeSH
- Biomarkers MeSH
- Diagnosis, Differential MeSH
- Child MeSH
- Adult MeSH
- Glatiramer Acetate * administration & dosage therapeutic use MeSH
- Injections, Subcutaneous * methods trends utilization MeSH
- Interferon-beta therapeutic use drug effects MeSH
- Smoking MeSH
- Humans MeSH
- Magnetic Resonance Imaging methods utilization MeSH
- Methylprednisolone therapeutic use MeSH
- Adolescent MeSH
- Vitamin D Deficiency MeSH
- Risk Factors MeSH
- Multiple Sclerosis * diagnosis epidemiology drug therapy MeSH
- Herpesvirus 4, Human isolation & purification pathogenicity MeSH
- Evoked Potentials, Visual MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Female MeSH
- Publication type
- Case Reports MeSH
- MeSH
- Diabetes Mellitus, Type 2 * drug therapy MeSH
- Glucagon-Like Peptide 1 administration & dosage therapeutic use MeSH
- Glycated Hemoglobin isolation & purification metabolism drug effects MeSH
- Drug Evaluation methods utilization MeSH
- Injections, Subcutaneous utilization MeSH
- Incretins * metabolism therapeutic use MeSH
- Clinical Trials as Topic MeSH
- Blood Glucose isolation & purification metabolism drug effects MeSH
- Humans MeSH
- Drug-Related Side Effects and Adverse Reactions MeSH
- Receptors, Peptide * therapeutic use MeSH
- Statistics as Topic MeSH
- Venoms therapeutic use MeSH
- Check Tag
- Humans MeSH
